ARRY-502   Click here for help

GtoPdb Ligand ID: 10179

Synonyms: ARRY502 | example 237, enantiomer 1 [WO2009158426A1]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: ARRY-502 is an oral, potent and selective prostaglandin D2 receptor 2 (DP2) antagonist. It is the (4S) enantiomer of one of the chemical structures (example 237) claimed in Array Biopharma's patent WO2009158426A1
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 94.09
Molecular weight 515.09
XLogP 5.22
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(Cl)ccc1CCNC(=O)c1ccc(cc1)Oc1cc2OCCC(c2cc1Cl)C(=O)O
Isomeric SMILES COc1cc(Cl)ccc1CCNC(=O)c1ccc(cc1)Oc1cc2OCC[C@@H](c2cc1Cl)C(=O)O
InChI InChI=1S/C26H23Cl2NO6/c1-33-22-12-17(27)5-2-15(22)8-10-29-25(30)16-3-6-18(7-4-16)35-24-14-23-20(13-21(24)28)19(26(31)32)9-11-34-23/h2-7,12-14,19H,8-11H2,1H3,(H,29,30)(H,31,32)/t19-/m0/s1
InChI Key QIDYUNXQPQEJEC-IBGZPJMESA-N
Immunopharmacology Comments
ARRY-502 was designed to treat the symptoms of Th2-driven allergic diseases such as atopic dermatitis, allergic rhinitis and asthma, via antagonism of DP2 receptor signalling through Th2 inflammatory pathways in T cells, basophils and eosinophils [1-2].